Literature DB >> 18490741

Both Th1 and Th17 are immunopathogenic but differ in other key biological activities.

Catherine A Cox1, Guangpu Shi, Hongen Yin, Barbara P Vistica, Eric F Wawrousek, Chi-Chao Chan, Igal Gery.   

Abstract

The role of Th17 lymphocytes in immunopathogenic processes has been well established, but little is known about their basic cell features. In this study, we compared polarized Th1 and Th17 for key biological activities related to pathogenicity and trafficking. Th1 and Th17 lineages were derived from TCR-transgenic CD4 murine cells specific against hen egg lysozyme. When adoptively transferred into mice expressing hen egg lysozyme in their eyes, both Th1 and Th17 induced ocular inflammation but with slight differences in histological pathology. PCR analysis revealed selective expression of IFN-gamma or IL-17 in eyes of Th1 or Th17 recipients, respectively. Additionally, Th1 and Th17 were found to differ in three other key activities: 1) Th17 cells were inferior to Th1 cells in their capacity to trigger massive lymphoid expansion and splenomegaly; 2) the proportion of Th1 cells among infiltrating cells in inflamed recipient eyes declined rapidly, becoming a minority by day 7, whereas Th17 cells remained in the majority throughout this period; and 3) remarkable differences were noted between Th1 and Th17 cells in their expression of certain surface markers. In particular, reactivated Th1 expressed higher levels of CD49d and alpha(4)beta(7) (mucosal homing) in vitro and higher levels of CXCR3 (Th1 trafficking) in vivo. Reactivated Th17, however, expressed higher levels of alpha(E)beta(7) (epithelial tissue homing) and CD38 (activation, maturation and trafficking) in vitro, but in vivo Th17 expressed higher levels of alpha(4)beta(7) and CCR6 (lymphocyte trafficking). These data reveal that Th1 and Th17 cells differ in several key biological activities influencing migration and pathogenic behavior during inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490741      PMCID: PMC2753359          DOI: 10.4049/jimmunol.180.11.7414

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

Review 1.  Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation.

Authors:  Klaus Ley; Geoffrey S Kansas
Journal:  Nat Rev Immunol       Date:  2004-05       Impact factor: 53.106

2.  Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo.

Authors:  A Hamann; D P Andrew; D Jablonski-Westrich; B Holzmann; E C Butcher
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

Review 3.  The role of activated T lymphocytes in gastrointestinal disease.

Authors:  T T MacDonald
Journal:  Clin Exp Allergy       Date:  1990-05       Impact factor: 5.018

4.  Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis.

Authors:  R R Caspi; C C Chan; Y Fujino; F Najafian; S Grover; C T Hansen; R L Wilder
Journal:  J Neuroimmunol       Date:  1993-09       Impact factor: 3.478

5.  Conjunctival-associated lymphoid tissue: evidence for a role in the secretory immune system.

Authors:  R M Franklin; L E Remus
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-02       Impact factor: 4.799

6.  Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis.

Authors:  Takeru Yoshimura; Koh-Hei Sonoda; Yoshiyuki Miyazaki; Yoichiro Iwakura; Tatsuro Ishibashi; Akihiko Yoshimura; Hiroki Yoshida
Journal:  Int Immunol       Date:  2007-12-21       Impact factor: 4.823

7.  Selective alpha4beta7 integrin antagonists and their potential as antiinflammatory agents.

Authors:  Nathan J P Dubree; Dean R Artis; Georgette Castanedo; James Marsters; Daniel Sutherlin; Lisa Caris; Kevin Clark; Susan M Keating; Maureen H Beresini; Henry Chiu; Sherman Fong; Henry B Lowman; Nicholas J Skelton; David Y Jackson
Journal:  J Med Chem       Date:  2002-08-01       Impact factor: 7.446

8.  Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice.

Authors:  Susumu Nakae; Aya Nambu; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

9.  A unique pattern of up- and down-regulation of chemokine receptor CXCR3 on inflammation-inducing Th1 cells.

Authors:  Jun Chen; Barbara P Vistica; Hiroshi Takase; Don Il Ham; Robert N Fariss; Eric F Wawrousek; Chi-Chao Chan; Julie A DeMartino; Joshua M Farber; Igal Gery
Journal:  Eur J Immunol       Date:  2004-10       Impact factor: 5.532

10.  Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.

Authors:  Tessa Ten Hove; F The Olle; Marloes Berkhout; Joost P Bruggeman; Florry A Vyth-Dreese; J Frederik M Slors; Sander J H Van Deventer; Anje A Te Velde
Journal:  J Leukoc Biol       Date:  2004-03-12       Impact factor: 4.962

View more
  33 in total

1.  PD-L1(hi) retinal pigment epithelium (RPE) cells elicited by inflammatory cytokines induce regulatory activity in uveitogenic T cells.

Authors:  Yan Ke; Deming Sun; Guomin Jiang; Henry J Kaplan; Hui Shao
Journal:  J Leukoc Biol       Date:  2010-08-25       Impact factor: 4.962

Review 2.  Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant.

Authors:  Anna U Bielinska; Michele Gerber; Luz P Blanco; Paul E Makidon; Katarzyna W Janczak; Michael Beer; Benjamin Swanson; James R Baker
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

3.  GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice.

Authors:  Tim D Boyd; Steven P Bennett; Takashi Mori; Nicholas Governatori; Melissa Runfeldt; Michelle Norden; Jaya Padmanabhan; Peter Neame; Inge Wefes; Juan Sanchez-Ramos; Gary W Arendash; Huntington Potter
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Intercellular adhesion molecule 1 mediates migration of Th1 and Th17 cells across human retinal vascular endothelium.

Authors:  Arpita S Bharadwaj; Lauren P Schewitz-Bowers; Lai Wei; Richard W J Lee; Justine R Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-23       Impact factor: 4.799

5.  Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site.

Authors:  Cuiyan Tan; Mehak K Aziz; Jenna D Lovaas; Barbara P Vistica; Guangpu Shi; Eric F Wawrousek; Igal Gery
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

6.  Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells.

Authors:  Guangpu Shi; Catherine A Cox; Barbara P Vistica; Cuiyan Tan; Eric F Wawrousek; Igal Gery
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Cell-cell interaction with APC, not IL-23, is required for naive CD4 cells to acquire pathogenicity during Th17 lineage commitment.

Authors:  Guangpu Shi; Jenna D Lovaas; Cuiyan Tan; Barbara P Vistica; Eric F Wawrousek; Mehak K Aziz; Rachael C Rigden; Rachel R Caspi; Igal Gery
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

Review 8.  Plasticity of T-cell phenotype and function: the T helper type 17 example.

Authors:  Ariana Peck; Elizabeth D Mellins
Journal:  Immunology       Date:  2009-11-17       Impact factor: 7.397

9.  Comparison of sensitivity of Th1, Th2, and Th17 cells to Fas-mediated apoptosis.

Authors:  Yujiang Fang; Shiguang Yu; Jason S Ellis; Tumenjargal Sharav; Helen Braley-Mullen
Journal:  J Leukoc Biol       Date:  2010-06       Impact factor: 4.962

10.  Shedding New Light on the Process of "Licensing" for Pathogenicity by Th Lymphocytes.

Authors:  Cuiyan Tan; Wambui S Wandu; R Steven Lee; Samuel H Hinshaw; Dennis M Klinman; Eric Wawrousek; Igal Gery
Journal:  J Immunol       Date:  2016-12-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.